Xcout IntelPHYSIOMICS PLC
Founded in 2001 and headquartered in Oxford, UK, Physiomics Plc offers expert consulting services to pharmaceutical enterprises across the United Kingdom, the United States, and the European Union. The company's core specialization lies in outsourced quantitative pharmacology and computational biology. They deliver comprehensive modeling, simulation, and data analysis services primarily focused on oncology research and development, utilizing their proprietary Virtual Tumour predictive software. Additionally, Physiomics is engaged in developing innovative technologies for applications within the field of personalized medicine.
Subscribe to see PHYSIOMICS PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PHYSIOMICS PLC at a glance
PHYSIOMICS PLC is a biotech company headquartered in Oxford, United Kingdom, founded in 2001. It is publicly listed (PYC) with a market capitalisation of $2M.
PHYSIOMICS PLC competitors
A few of PHYSIOMICS PLC's closest competitors — see the full list of competitors and alternatives →
VeriSIM Life provides an AI-driven drug discovery and development platform called BIOiSIM that uses mechanistic and quantitative methods to predict patient outcomes and de-risk clinical trials. The company serves pharmaceutical companies, biotechnology firms, and academic research institutions by generating actionable insights for drug repurposing, safety-toxicity profiles, and efficacy predictions.
Plato BioPharma, Inc. is a life sciences company headquartered in Westminster, Colorado, that offers expert preclinical drug discovery and pharmacological research services.
Hubrecht Organoid Technology (HUB) develops patented patient-derived organoid technology from healthy and diseased tissues to predict patient responses to treatments. The company functions as a contract research organization (CRO), offering drug discovery services, custom model and assay development, clinical trials in a dish, and licensing programs for pharmaceutical and research applications.
WuXi Biology provides a comprehensive spectrum of preclinical biology services and solutions for drug discovery, supporting clients from target discovery and validation to hit finding, lead optimization, and candidate selection. The company offers specialized platforms and expertise across major disease areas and therapeutic modalities, including small molecules, oligonucleotides, peptides, and antibodies.
Propria provides contract research services for pharmaceutical and scientific organizations, specializing in in vitro cardiac contractility testing using proprietary human engineered heart tissues. The company evaluates disease models, new compounds, and gene therapies through contractile profiling and functional cardiac reserve assessments to help predict human pharmacology and de-risk drug discovery.
Crown Bioscience is a global contract research organization (CRO) headquartered in California that specializes in translational oncology and immuno-oncology drug discovery and development. The company provides comprehensive discovery, preclinical, and translational research platforms.
Get PHYSIOMICS PLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on PHYSIOMICS PLC in Xcout Intel
- The full competitor set, tracking, exports and API access